1
’’), 133.9 (C-1’’’), 150.5 (C-4’), 155.1 (C-4’’), 164.1 (CCONH), 165.9 (CONHC) ppm. MS
+
m/z (ESI %): 416.2 ([M+H] ); HMRS: m/z (ESI) calc. for C H N O 416.1969, found
2
5
26
3
3
4
16.1990.
2
.2.2.
(E)-N-(1-(4-methoxyphenyl)-3-((4-methoxyphenyl)amino)-3-oxoprop-1-en-2-
yl)benzamide (3b)
1
The product was isolated as a white solid (0.319 g, 0.79 mmol, 73 %). M.p. = 233-235 ºC. H
NMR (300 MHz, DMSO-d ) δ = 3.74 (d, J = 1.8 Hz, 3H, OCH ), 3.77 (d, J = 1.6 Hz, 3H,
6
3
OCH ), 6.90 (dd, J = 8.9 and 1.8 Hz, 2H, H-3’’,5’’), 6.96 (dd, J = 8.4 and 1.6 Hz, 2H, H-
3
3
’,5’), 7.17 (s, 1H, CH), 7.51-7.64 (m, 7H, H-2’,6’, H-2’’,6’’, H-3’’’,5’’’ and H-4’’’), 8.05 (d,
1
3
J = 8.1 Hz, 2H, H-2’’’,6’’’), 9.94 (s, 1H, NH), 10.00 (s, 1H, NH) ppm. C NMR (75 MHz,
DMSO-d ) δ = 55.1 (OCH ), 55.2 (OCH ), 113.6 (C-3’’,5’’), 114.0 (C-3’,5’), 121.7 (C-
6
3
3
2
’’,6’’), 126.7 (C-1’), 127.9 (C-2’’’,6’’’), 128.3(C-2’,6’), 128.5 (CH), 128.8 (C-4’’’), 131.1
(
1
C-3’’’,5’’’), 131.7 (NHCCO), 132.4 (C-1’’), 133.6 (C-1’’’), 155.3(C-4’’), 159.5 (C-4’),
64.1 (CCONH), 165.9 (CONHC) ppm. MS m/z (ESI %): 403.2 ([M+H] ); HMRS: m/z (ESI)
+
calc. for C H N O 403.1652, found 403.1669.
2
4
23
2
4
2
.2.3.
(E)-N-(1-(4-nitroxyphenyl)-3-((4-methoxyphenyl)amino)-3-oxoprop-1-en-2-
yl)benzamide (3c)
1
The product was isolated as a white solid (0.143 g, 0.34 mmol, 50%). M.p. = 232-233 ºC. H
NMR (300 MHz, DMSO-d ) δ = 3.74 (br s, 3H, OCH ), 6.92 (d, J = 9.0 Hz, 2H, H-3’’,5’’),
6
3
7
2
.15 (s, 1H, CH), 7.51-7.66 (m, 5H, H-2’’,6’’, H-3’’’,5’’’ and H-4’’’), 7.86 (d, J = 8.6 Hz,
H, H-2’,6’), 8.01 (d, J = 8.5 Hz, 2H, H-2’’’,6’’’), 8.25 (d, J = 8.6 Hz, H-3’,5’), 10.23 (s, 1H,
13
NH), 10.27 (s, 1H, NH) ppm. C NMR (75 MHz, DMSO-d ) δ = 55.2 (OCH ), 113.7 (C-
6
3
3
3
1
’’,5’’), 121.5 (C-2’’,6’’), 123.6 (C-3’,5’), 124.4 (CH), 128.0 (C-2’’’,6’’’), 128.4 (C-
’’’,5’’’), 130.2 (C-2’,6’), 132.0 (C-4’’’), 132.2 (C-1’’), 133.2 (C-1’’’), 134.5 (NHCCO),
41.6 (C-1’ or C-4’), 146.4 (C-1’ or C-4’), 155.5 (C-4’’), 163.5 (CCONH), 165.9 (CONHC)
+
ppm. MS m/z (ESI %): 418.1 ([M+H] ); HMRS: m/z (ESI) calc. for C H N O 418.1397,
2
3
20
3
5
found 418.1418.
2
.3. General procedure for the synthesis of Imidazolone derivatives 4a-c
Anhydrous ZnCl (2.5 mmol) was added to the benzamide derivative (0.5 mmol) in toluene
2
(
10 mL). The reaction mixture was refluxed for 5-18 h followed by addition of H O (25 mL),
2
the pH was adjusted to 3-4 with diluted HCl and the solution extracted with CH Cl (3×25
2
2
mL). The organic layer was collected, dried with anhydrous Na SO , and the solvent was
2
4
evaporated to give a solid residue that was purified by silica gel column chromatography
using dichloromethane as eluent.
2
.3.1. (Z)-5-(4-(dimethylamino)benzylidene)-3-(4-methoxyphenyl)-2-phenyl-3,5-dihydro-4H-
imidazol-4-one (4a)
The product was isolated as an orange solid (0.112 g, 0.28 mmol, 55 %); R 0.46 (CH Cl ).
f
2
2
1
M.p. = 263-264 ºC. H NMR (300 MHz, CDCl ) δ = 3.09 (s, 6H, N(CH ) ), 3.83 (s, 3H,
3
3 2
OCH ), 6.75 (d, J = 8.5 Hz, 2H, H-3’,5’), 6.93 (dd, J = 8.9 and 1.1 Hz, 2H, H-3’’,5’’), 7.11
3
(dd, J = 8.9 and 1.1 Hz, 2H, H-2’’,6’’), 7.27-7.33 (m, 2H, H-3’’’,5’’’), 7.30 (s, 1H, CH), 7.36-
7
.42 (m, 1H, H-4’’’), 7.58 (dd, J = 8.4 and 1.5 Hz, 2H, H-2’’’,6’’’), 8.23 (d, J = 8.5 Hz, 2H,
1
3
H-2’,6’) ppm. C NMR (75 MHz, CDCl ) δ = 40.2 (N(CH ) ), 55.6 (OCH ), 111.9 (C-3’,5’),
3
3 2
3
1
2
14.8 (C-3’’,5’’), 122.7 (C-1’), 128.1 (C-1’’), 128.3 (C-3’’’,5’’’), 128.7 (C-2’’,6’’), 129.1 (C-
’’’,6’’’), 129.6 (C-4), 130.7 (C-4’’’), 131.0 (CH), 134.7 (C-1’’’), 134.9 (C-2’,6’), 151.9 (C-